Reporting Checklist 2016 This checklist is intended to the reporting of clinical practice guidelines. CHECKLIST ITEM AND DESCRIPTION REPORTING CRITERIA Page # DOMAIN 1: SCOPE AND PURPOSE 1. OBJECTIVES Report the overall objective(s) of the guideline. The expected health benefits from the guideline are to be specific to the clinical problem or health topic. Health intent(s) (i.e., prevention, screening, diagnosis, treatment, etc.) Expected benefit(s) or outcome(s) Target(s) (e.g., patient population, society) 2. QUESTIONS Report the health question(s) covered by the guideline, particularly for the key recommendations. Target population Intervention(s) or exposure(s) Comparisons (if appropriate) Outcome(s) Health care setting or context 3. POPULATION Describe the population (i.e., patients, public, etc.) to whom the guideline is meant to apply. Target population, sex and age Clinical condition (if relevant) Severity/stage of disease (if relevant) Comorbidities (if relevant) Excluded populations (if relevant) DOMAIN 2: STAKEHOLDER INVOLVEMENT 4. GROUP MEMBERSHIP Report all individuals who were involved in the development process. This may include members of the steering group, the research team involved in selecting and reviewing/rating the evidence and individuals involved in formulating the final recommendations. Name of participant Discipline/content expertise (e.g., neurosurgeon, methodologist) Institution (e.g., St. Peter’s hospital) Geographical location (e.g., Seattle, WA) A description of the member’s role in the guideline development 5. TARGET POPULATION PREFERENCES AND VIEWS Report how the views and preferences of the target population were sought/considered and what the resulting outcomes were. Statement of type of strategy used to capture patients’/publics’ views and preferences (e.g., participation in the guideline development group, literature review of values and preferences) Methods by which preferences and views were sought (e.g., evidence from literature, surveys, focus groups) Outcomes/information gathered on patient/public information How the information gathered was used to inform the guideline development process and/or formation of the recommendations 6. TARGET USERS Report the target (or intended) users of the guideline. The intended guideline audience (e.g. specialists, family physicians, patients, clinical or institutional leaders/administrators)
Reporting of the balance/trade-off between benefits and harms/side effects/risks Recommendations reflect considerations of both benefits and harms/side effects/risks 12. LINK BETWEEN RECOMMENDATIONS AND EVIDENCE Describe the explicit link between the recommendations and the evidence on which they are based. How the guideline development group linked and used the evidence to inform recommendations Link between each recommendation and key evidence (text description and/or reference list) Link between recommendations and evidence summaries and/or evidence tables in the results section of the guideline 13. EXTERNAL REVIEW Report the methodology used to conduct the external review. Purpose and intent of the external review (e.g., to improve quality, gather feedback on draft recommendations, assess applicability and feasibility, disseminate evidence) Methods taken to undertake the external review (e.g., rating scale, open-ended questions) Description of the external reviewers (e.g., number, type of reviewers, affiliations) Outcomes/information gathered from the external review (e.g., summary of key findings) How the information gathered was used to inform the guideline development process and/or formation of the recommendations (e.g., guideline panel considered results of review in forming final recommendations) 14. UPDATING PROCEDURE Describe the procedure for updating the guideline. A statement that the guideline will be updated Explicit time interval or explicit criteria to guide decisions about when an update will occur Methodology for the updating procedure DOMAIN 4: CLARITY OF PRESENTATION 15. SPECIFIC AND UNAMBIGUOUS RECOMMENDATIONS Describe which options are appropriate in which situations and in which population groups, as informed by the body of evidence. A statement of the recommended action Intent or purpose of the recommended action (e.g., to improve quality of life, to decrease side effects) Relevant population (e.g., patients, public) Caveats or qualifying statements, if relevant (e.g., patients or conditions for whom the recommendations would not apply) If is uncertainty about the best care option(s), the uncertainty should be stated in the guideline 16. MANAGEMENT OPTIONS Describe the different options for managing the condition or health issue. Description of management options Population or clinical situation most appropriate to each option